Hamilton Thorne Ltd. (HTL.V)
| Previous Close | 1.6500 |
| Open | 1.6500 |
| Bid | 1.6500 x 0 |
| Ask | 1.6900 x 0 |
| Day's Range | 1.6500 - 1.6500 |
| 52 Week Range | 1.3100 - 2.2000 |
| Volume | |
| Avg. Volume | 30,749 |
| Market Cap | 238.285M |
| Beta (5Y Monthly) | 0.83 |
| PE Ratio (TTM) | 55.00 |
| EPS (TTM) | 0.0300 |
| Earnings Date | Nov 21, 2022 - Nov 25, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 2.62 |
- GlobeNewswire
Hamilton Thorne to Participate in the 6th Annual Lake Street Capital Markets Best Ideas Growth Conference
BEVERLY, Mass. and TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will participate in the 6th Annual Lake Steet Capital Markets Best Ideas Growth Conference being held at the Yale Club in New York, NY on September 14, 2022. David Wolf, President and CEO, and Francesco F
- GlobeNewswire
Hamilton Thorne Reports Financial and Operational Results for the Quarter and Six Months Ended June 30, 2022
Revenues up 14% for the quarter and 18% for the six months despite supply chain issues and significant foreign currency swingsBEVERLY, Mass. and TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results for the quarter and six months ended June 30, 2022. Highlights S
- GlobeNewswire
Hamilton Thorne to Announce Q2 Financial Results and Hold Conference Call on August 23, 2022
BEVERLY, Mass. and TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three- and six-month periods ended June 30, 2022 before market open on Tuesday, August 23, 2022. The press release, with accompanying financial information, will be posted
